AAAAAA

   
Results: 1-16 |
Results: 16
Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands
Authors: Emond, P Helfenbein, J Chalon, S Garreau, L Vercouillie, J Frangin, Y Besnard, JC Guilloteau, D
Citation: P. Emond et al., Synthesis of tropane and nortropane analogues with phenyl substitutions asserotonin transporter ligands, BIO MED CH, 9(7), 2001, pp. 1849-1855
Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases
Authors: Prunier, C Tranquart, F Cottier, JP Giraudeau, B Chalon, S Guilloteau, D De Toffol, B Chossat, F Autret, A Besnard, JC Baulieu, JL
Citation: C. Prunier et al., Quantitative analysis of striatal dopamine D2 receptors with I-123-iodolisuride SPECT in degenerative extrapyramidal diseases, NUCL MED C, 22(11), 2001, pp. 1207-1214
Characterization of Tc-99m-DTPA aerosols for lung permeability studies
Authors: Diot, P Galinier, E Grimbert, D Bugeon, S Valat, C Lemarie, E Diot, E Baulieu, JL Besnard, JC Guilloteau, D
Citation: P. Diot et al., Characterization of Tc-99m-DTPA aerosols for lung permeability studies, RESPIRATION, 68(3), 2001, pp. 313-317
[I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors
Authors: Baulieu, JL Resche, I Bardies, M Chauvet, AF Lecloirec, J Malhaire, JP Thomas, E Faurous, P Sassolas, G Pourcelot, L Chatal, JF Guilloteau, D Besnard, JC
Citation: Jl. Baulieu et al., [I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors, NUCL MED BI, 27(8), 2000, pp. 809-813
Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide
Authors: Gouhier, C Chalon, S Venier-Julienne, MC Bodard, S Benoit, JP Besnard, JC Guilloteau, D
Citation: C. Gouhier et al., Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide, NEUROSCI L, 288(1), 2000, pp. 71-75
Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains
Authors: Zimmer, L Kodas, E Guilloteau, D Garreau, L Besnard, JC Chalon, S
Citation: L. Zimmer et al., Microdialysis as a tool for in vivo study of dopamine transporter functionin rat brains, J NEUROSC M, 103(2), 2000, pp. 137-144
Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids
Authors: Zimmer, L Delion-Vancassel, S Durand, G Guilloteau, D Bodard, S Besnard, JC Chalon, S
Citation: L. Zimmer et al., Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids, J LIPID RES, 41(1), 2000, pp. 32-40
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I
Authors: Hall, H Halldin, C Guilloteau, D Chalon, S Emond, P Besnard, JC Farde, L Sedvall, G
Citation: H. Hall et al., Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [I-125]PE2I, NEUROIMAGE, 9(1), 1999, pp. 108-116
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter
Authors: Helfenbein, J Sandell, J Halldin, C Chalon, S Emond, P Okubo, Y Chou, YH Frangin, Y Douziech, L Gareau, L Swahn, CG Besnard, JC Farde, L Guilloteau, D
Citation: J. Helfenbein et al., PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter, NUCL MED BI, 26(5), 1999, pp. 491-499
Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease
Authors: Chalon, S Emond, P Bodard, S Vilar, MP Thiercelin, C Besnard, JC Guilloteau, D
Citation: S. Chalon et al., Time course of changes in striatal dopamine transporters and D-2 receptorswith specific iodinated markers in a rat model of Parkinson's disease, SYNAPSE, 31(2), 1999, pp. 134-139
Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach
Authors: Collet, C Lecomte, P Guilloteau, D Lejeune, B Lecomte, C Besnard, JC
Citation: C. Collet et al., Luteinizing hormone measurement in polycystic ovary syndrome: a practical approach, EUR J ENDOC, 141(3), 1999, pp. 225-230
Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET.
Authors: Helfenbein, J Emond, P Sandell, J Halldin, C Pereyre, S Frangin, Y Garreau, L Besnard, JC Guilloteau, D Chalon, S
Citation: J. Helfenbein et al., Synthesis and radiolabelling of 2 beta-carbomethoxy-3 beta-(3 '-iodo-4 '-isopropylphenyl) nortropane as a radioligand for the exploration of the serotonin transporter by SPET., J LABEL C R, 42(4), 1999, pp. 337-347
Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET
Authors: Baulieu, JL Ribeiro, MJ Levilion-Prunier, C Tranquart, F Chartier, JR Guilloteau, D Cottier, JP Besnard, JC Pourcelot, L Autret, A
Citation: Jl. Baulieu et al., Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET, NUCL MED C, 20(1), 1999, pp. 77-84
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments
Authors: Helfenbein, J Loc'h, C Bottlaender, M Emond, P Coulon, C Ottaviani, M Fuseau, C Chalon, S Guenther, I Besnard, JC Frangin, Y Guilloteau, D Maziere, B
Citation: J. Helfenbein et al., A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments, LIFE SCI, 65(25), 1999, pp. 2715-2726
Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter
Authors: Chalon, S Garreau, L Emond, P Zimmer, L Vilar, MP Besnard, JC Guilloteau, D
Citation: S. Chalon et al., Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2 beta-carboxymethoxy-3 beta-(4 '-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter, J PHARM EXP, 291(2), 1999, pp. 648-654
Dietary fish oil affects monoaminergic neurotransmission and behavior in rats
Authors: Chalon, S Delion-Vancassel, S Belzung, C Guilloteau, D Leguisquet, AM Besnard, JC Durand, G
Citation: S. Chalon et al., Dietary fish oil affects monoaminergic neurotransmission and behavior in rats, J NUTR, 128(12), 1998, pp. 2512-2519
Risultati: 1-16 |